Molecular Medicine and Chronic Diseases Research Center (CIMUS)
Singular centre
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublications in collaboration with researchers from Christie Hospital NHS Foundation Trust (7)
2022
2020
-
Divergent mutational processes distinguish hypoxic and normoxic tumours
Nature Communications, Vol. 11, Núm. 1
2017
-
Gefitinib and EGFR gene copy number aberrations in esophageal cancer
Journal of Clinical Oncology, Vol. 35, Núm. 20, pp. 2279-2287
2014
-
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904
-
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 829-840
-
Phase II trial of cetuximab and conformal radiotherapy only in locally advanced pancreatic cancer with concurrent tissue sampling feasibility study
Translational Oncology, Vol. 7, Núm. 1, pp. 55-64